Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Sector Analysis

UpdatedAug 15, 2025
DataAggregated Company Financials
Companies1382
  • 7D4.2%
  • 3M2.0%
  • 1Y-12.2%
  • YTD-3.7%

In the last week, the Healthcare industry is up 4.2%, with Eli Lilly up 6.8%. However, the industry is down 12% over the past year. Earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 15 Aug 2025US$5.6tUS$3.1tUS$136.9b23.4x40.5x1.8x
Sun, 13 Jul 2025US$5.5tUS$3.0tUS$127.9b24x43.3x1.8x
Tue, 10 Jun 2025US$5.5tUS$3.0tUS$127.2b23.8x43.2x1.8x
Thu, 08 May 2025US$5.4tUS$3.0tUS$127.1b25x42.7x1.8x
Sat, 05 Apr 2025US$5.5tUS$2.6tUS$82.1b24.7x67x2.1x
Mon, 03 Mar 2025US$5.9tUS$2.6tUS$79.3b27.5x74x2.2x
Wed, 29 Jan 2025US$6.2tUS$2.9tUS$85.5b27.9x72x2.1x
Fri, 27 Dec 2024US$5.9tUS$2.9tUS$78.3b27.6x74.8x2x
Sun, 24 Nov 2024US$6.0tUS$2.9tUS$77.3b28.2x78.1x2.1x
Tue, 22 Oct 2024US$6.2tUS$2.8tUS$58.7b32.1x106.4x2.2x
Thu, 19 Sep 2024US$6.3tUS$2.8tUS$60.2b31.1x104.5x2.2x
Sat, 17 Aug 2024US$6.1tUS$2.8tUS$56.1b32.8x109.5x2.2x
Mon, 15 Jul 2024US$6.3tUS$2.8tUS$62.2b31.2x101.7x2.2x
Wed, 12 Jun 2024US$6.2tUS$2.8tUS$63.6b30.2x97.9x2.2x
Fri, 10 May 2024US$6.1tUS$2.8tUS$62.9b30.6x96.7x2.2x
Sun, 07 Apr 2024US$6.2tUS$2.8tUS$84.1b32.4x73.2x2.2x
Tue, 05 Mar 2024US$6.3tUS$2.8tUS$85.0b31x74x2.3x
Thu, 01 Feb 2024US$6.4tUS$2.8tUS$80.6b31.6x79.2x2.3x
Sat, 30 Dec 2023US$6.2tUS$2.8tUS$91.5b32.6x68.2x2.2x
Mon, 27 Nov 2023US$5.9tUS$2.8tUS$91.4b28.6x64.4x2.1x
Wed, 25 Oct 2023US$5.7tUS$2.8tUS$99.6b24.8x57.3x2x
Fri, 22 Sep 2023US$5.9tUS$2.8tUS$98.6b27.4x60.1x2.1x
Sun, 20 Aug 2023US$6.1tUS$2.8tUS$99.2b27.9x61.4x2.2x
Tue, 18 Jul 2023US$6.0tUS$2.7tUS$110.9b26.1x54x2.2x
Thu, 15 Jun 2023US$6.0tUS$2.7tUS$110.1b25.6x54.1x2.2x
Sat, 13 May 2023US$6.0tUS$2.7tUS$114.6b24.7x52.3x2.2x
Mon, 10 Apr 2023US$5.9tUS$2.5tUS$124.4b24.6x47.6x2.4x
Wed, 08 Mar 2023US$5.7tUS$2.5tUS$122.3b24.8x46.5x2.3x
Fri, 03 Feb 2023US$6.0tUS$2.5tUS$135.3b23.8x44.5x2.4x
Sun, 01 Jan 2023US$6.1tUS$2.5tUS$135.6b23.1x44.7x2.5x
Tue, 29 Nov 2022US$6.0tUS$2.4tUS$133.6b23.8x44.8x2.5x
Thu, 27 Oct 2022US$5.8tUS$2.4tUS$157.4b22.8x37.1x2.4x
Sat, 24 Sep 2022US$5.5tUS$2.4tUS$155.9b20.7x35.4x2.3x
Mon, 22 Aug 2022US$6.0tUS$2.4tUS$157.0b24x38.4x2.5x
Price to Earnings Ratio

38.4x


Total Market Cap: US$6.0tTotal Earnings: US$157.0bTotal Revenue: US$2.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 64.5x202320242025
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 40.5x which is lower than its 3-year average PE of 64.5x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 4.5% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market1.65%
Healthcare4.18%
Healthcare Services6.98%
Life Sciences6.40%
Biotech4.56%
Pharma4.46%
Medical Equipment1.25%
Healthtech0.47%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 57.4x.
    • Analysts are expecting annual earnings growth of 12.8%, which is lower than the prior year's growth of 16.6% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 25% over the next 5 years.
  • However this is lower than its past earnings growth rate of 69% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LLY Eli LillyUS$684.436.8%
+US$39.1b		-26.5%PE44.5x
UNH UnitedHealth GroupUS$271.4911.0%
+US$23.9b		-53.2%PE11.5x
TMO Thermo Fisher ScientificUS$485.046.7%
+US$11.4b		-19.7%PE27.8x
GILD Gilead SciencesUS$119.027.9%
+US$10.8b		60.1%PE23.4x
ABBV AbbVieUS$204.682.9%
+US$10.3b		5.8%PE97.1x

Latest News

ICUI
US$111.90
ICU Medical
7D
-13.9%
1Y
-29.2%
LLY
US$684.43
Eli Lilly
7D
6.8%
1Y
-26.5%
SMMT
US$26.45
Summit Therapeutics
7D
-5.8%
1Y
122.8%
UNH
US$271.49
UnitedHealth Group
7D
11.0%
1Y
-53.2%
CAH
US$150.22
Cardinal Health
7D
-2.1%
1Y
39.2%
MRK
US$82.76
Merck
7D
3.0%
1Y
-27.0%

Shareholders Can Be Confident That Merck's (NYSE:MRK) Earnings Are High Quality

Aug 12
Shareholders Can Be Confident That Merck's (NYSE:MRK) Earnings Are High Quality
TMO
US$485.04
Thermo Fisher Scientific
7D
6.7%
1Y
-19.7%
HIMS
US$47.13
Hims & Hers Health
7D
-7.7%
1Y
200.0%
DHR
US$210.22
Danaher
7D
5.9%
1Y
-21.9%
GILD
US$119.02
Gilead Sciences
7D
7.9%
1Y
60.1%
ABBV
US$204.68
AbbVie
7D
2.9%
1Y
5.8%
STVN
US$22.17
Stevanato Group
7D
-8.4%
1Y
10.9%

Here's What Analysts Are Forecasting For Stevanato Group S.p.A. (NYSE:STVN) After Its Second-Quarter Results

Aug 08
Here's What Analysts Are Forecasting For Stevanato Group S.p.A. (NYSE:STVN) After Its Second-Quarter Results
VEEV
US$274.98
Veeva Systems
7D
-1.7%
1Y
42.6%
HQY
US$87.43
HealthEquity
7D
-4.8%
1Y
18.8%
JNJ
US$174.72
Johnson & Johnson
7D
1.9%
1Y
9.8%
ABT
US$129.28
Abbott Laboratories
7D
-2.1%
1Y
16.5%